# INSM2

## Overview
INSM2, or insulinoma-associated 2, is a gene that encodes the INSM transcriptional repressor 2 protein, which is a critical regulator in the development and function of pancreatic islet cells. This protein functions as a transcriptional repressor, influencing gene expression by binding to DNA and inhibiting the transcription of specific genes. It plays a pivotal role in glucose metabolism and insulin secretion, primarily by modulating the activity of key transcription factors such as Neurogenin3 (Ngn3) and NeuroD1, which are essential for islet cell development (Wang2018Targeted). The INSM2 protein is predominantly active in the nucleus of developing endocrine cells, where it contributes to cell differentiation and tissue development. Its absence has been linked to impaired insulin secretion and glucose intolerance, highlighting its importance in maintaining glucose homeostasis (Wang2018Targeted). Although direct associations with human diseases are not fully established, alterations in INSM2 expression or function may have implications for diabetes-related conditions (Wang2018Targeted).

## Structure


## Function
INSM2, also known as insulinoma-associated 2, is a transcriptional repressor that plays a significant role in the development and function of pancreatic islet cells and glucose metabolism. It is directly targeted by the transcription factors Neurogenin3 (Ngn3) and NeuroD1, which are essential for islet cell development and function (Wang2018Targeted). INSM2 is expressed in developing endocrine cells and is involved in glucose-stimulated insulin secretion, indicating its importance in maintaining normal glucose levels in the body (Wang2018Targeted).

In healthy cells, INSM2 is active in the nucleus, where it regulates gene expression by binding to DNA and inhibiting the transcription of specific genes. This activity influences cell differentiation and development, affecting cell fate decisions and tissue development (Wang2018Targeted). The absence of INSM2 leads to reduced insulin secretion and glucose intolerance, as observed in studies with Insm2-deficient mice, which exhibit higher fasting blood glucose levels and lower insulin/C-peptide levels compared to wild-type mice (Wang2018Targeted). These findings underscore the critical role of INSM2 in insulin secretion and glucose metabolism, contributing to the proper functioning of neuroendocrine tissues (Wang2018Targeted).

## Clinical Significance
Mutations or alterations in the expression of the INSM2 gene have been implicated in various physiological and potentially pathological conditions. Research has shown that targeted deletion of the Insm2 gene in mice leads to significant changes in glucose metabolism, including elevated fasting blood glucose levels and reduced glucose tolerance. These findings suggest that INSM2 plays a crucial role in insulin secretion and glucose homeostasis, and its dysregulation may contribute to conditions such as diabetes (Wang2018Targeted).

In Insm2-deficient mice, there is a marked reduction in insulin and C-peptide levels, along with decreased transcriptional levels of insulin genes Ins1 and Ins2. This indicates that INSM2 is essential for proper insulin production and secretion, and its absence can lead to glucose intolerance (Wang2018Targeted). The study also observed compensatory increases in the expression of other transcription factors like Insm1, Ngn3, and NeuroD1, which are involved in islet development and function, suggesting that these factors may partially mitigate the effects of INSM2 deficiency (Wang2018Targeted).

While direct links to specific human diseases are not established, the role of INSM2 in glucose metabolism and insulin secretion implies that its alterations could potentially contribute to diabetes-related conditions (Wang2018Targeted).


## References


[1. (Wang2018Targeted) Lin Wang, Zhong Sheng Sun, Bingwu Xiang, Chi-ju Wei, Yan Wang, Kevin Sun, Guanjie Chen, Michael S. Lan, Gilberto N. Carmona, Abner L. Notkins, and Tao Cai. Targeted deletion of insm2 in mice result in reduced insulin secretion and glucose intolerance. Journal of Translational Medicine, October 2018. URL: http://dx.doi.org/10.1186/s12967-018-1665-6, doi:10.1186/s12967-018-1665-6. This article has 8 citations and is from a peer-reviewed journal.](https://doi.org/10.1186/s12967-018-1665-6)